Celecoxib
- Level
- Commodity
- Parent
- 51384600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384607This classification denotes a cyclooxygenase inhibitor with the molecular formula C17H14F3N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JCX84Q7J1L, chemically known as benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)- but generally known as celecoxib, which bears US NIH Compound Identifier 2662. European Medicines Agency schedules Celecoxib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01143MIG. The term CELECOXIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). World Health Organization schedules celecoxib in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule celecoxib under HS 29350090 and SITC 51580. As of Q4 2014, CELECOXIB remains the US FDA Preferred Term for this commodity. Celecoxib bears US NLM identifiers UMLS ID C0538927 and NCI Concept Code C1728. SMILES: S(=O)(=O)(N)C1CCC(N2NC(CC2C2CCC(CC2)C)C(F)(F)F)CC1.
Same parent
Under 51384600 · 33Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.